Research

Select your preferred filtration to narrow the articles shown.

April 6, 2022 | Peer Reviewed: Yes | Publication Type: Review/Commentary/Letter

A review of fluvoxamine’s ability to prevent hospitalization in COVID-19

Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis
March 3, 2022 | Peer Reviewed: Yes | Publication Type: Original , Clinical Prospective

Fluvoxamine treatment of patients with symptomatic COVID-19 in a community treatment center in Korea

Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
February 20, 2022 | Peer Reviewed: Yes | Publication Type: Original , Clinical Prospective

Efficacy of oral famotidine in patients hospitalized with COVID-19

Efficacy of Oral Famotidine in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2
February 11, 2022 | Peer Reviewed: Yes | Publication Type: Original , Clinical Retrospective

Impact of famotidine on chances of survival in hospitalized COVID-19 patients

Efficacy of Various Treatment Modalities on Patient-related Outcome in Hospitalized COVID-19 Patients – A Retrospective Study
February 10, 2022 | Peer Reviewed: Yes | Publication Type: Original , Clinical Prospective

A Phase II trial of high-dose famotidine in non-hospitalized COVID-19 patients

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
February 7, 2022 | Peer Reviewed: Yes | Publication Type: Review/Commentary/Letter

Letter to the editor raises questions about fluvoxamine study in ICU patients

Fluvoxamine for COVID-19 ICU patients?
January 7, 2022 | Peer Reviewed: Yes | Publication Type: Review/Commentary/Letter

A review of fluvoxamine’s mechanisms of action against COVID-19

Mechanisms of action of fluvoxamine for COVID-19: a historical review
November 1, 2021 | Peer Reviewed: Yes | Publication Type: Original , Clinical Prospective

Efficacy and safety of fluvoxamine in COVID-19 patients admitted to Intensive Care Units (ICU)

Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls
October 27, 2021 | Peer Reviewed: Yes | Publication Type: Original , Clinical Prospective

A clinical trial examines the ability of fluvoxamine to reduce emergency room visits and hospitalizations in high-risk COVID-19 patients.

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
October 25, 2021 | Peer Reviewed: Yes | Publication Type: Original , Clinical Retrospective

Pre-hospitalization use of famotidine in US army veterans results in decreased risk of death from COVID-19

Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans